|
Delayed
Athens S.E.
15:16:19 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 4.080 EUR | +0.74% |
|
-3.55% | +13.02% |
| 04-18 | Evrofarma SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 04-17 | Evrofarma FY 2025 net profit at EUR 3.5 million, up 55% YoY | RE |
Chart: Technical Analysis
Athens S.E.EUR
| Markets | Quality | ||
|---|---|---|---|
Athens S.E.
| EVROF | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 4.31 | 4.31 | 4.23 |
| Spread/Res. | -5.34% | -5.34% | -3.55% |
| Spread/Supp. | +3.82% | +10.27% | +26.71% |
| Support | 3.93 | 3.7 | 3.22 |
- Stock Market
- Stocks
- EVROF Stock
- Charts Evrofarma SA
Select your edition
All financial news and data tailored to specific country editions
